Work

Supplementary Figure S3 from A MERTK-Targeting Antibody–Drug Conjugate Selectively Depletes M2 Tumor-Associated Macrophages and MERTK-Expressing Cancer Cells

Year: 2026

Type: supplementary-materials

Abstract: This figure shows characterization of RGX-019-MMAE and its control ADC

DOI: 10.1158/0008-5472.32714413

Authors: Shugaku Takeda, Subhasree Sridhar, Daniel Schefer, Celia Andreu-Agullo, Pui C. Lo, Minhee Lee, Robert Busby, David M. Darst, Anne Assmus, Suresh Anaganti, Nils Halberg, Benjamin N. Ostendorf, Ivo C. Lorenz, Sohail F. Tavazoie, Masoud F. Tavazoie, Isabel Kurth

Language: English

Topic: Immune cells in cancer

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7165001661

Cites:

Cited by:

Related to: 10